BIOVED PHARMACEUTICALS, INC. Trademark

Trademark Overview


On Wednesday, January 31, 2024, a trademark application was filed for BIOVED PHARMACEUTICALS, INC. with the United States Patent and Trademark Office. The USPTO has given the BIOVED PHARMACEUTICALS, INC. trademark a serial number of 98384761. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 4, 2025. This trademark is owned by Bioved Pharmaceuticals, Inc.. The BIOVED PHARMACEUTICALS, INC. trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements; Natural dietary supplements; Nutraceuticals for use as a dietary supplement; Plant and herb extracts, other than essential oils, for medicinal purposes; Plant extracts, other than essential oils, for medical, veterinary and pharmaceutical purposes; Plant extracts, other than essential oils, for pharmaceutical purposes
bioved pharmaceuticals, inc.

General Information


Serial Number98384761
Word MarkBIOVED PHARMACEUTICALS, INC.
Filing DateWednesday, January 31, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 4, 2025

Trademark Statements


Description of MarkThe mark consists of dark teal Bioved on white preceded by a green stylized leaf, Pharmaceuticals, Inc. in dark teal underneath "Bioved".
Goods and ServicesDietary supplements; Natural dietary supplements; Nutraceuticals for use as a dietary supplement; Plant and herb extracts, other than essential oils, for medicinal purposes; Plant extracts, other than essential oils, for medical, veterinary and pharmaceutical purposes; Plant extracts, other than essential oils, for pharmaceutical purposes
Indication of Colors claimedThe color(s) dark teal, white and green is/are claimed as a feature of the mark.
NOT AVAILABLE"Pharmaceuticals, Inc."

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 31, 2024
Primary Code005
First Use Anywhere DateSunday, May 1, 2011
First Use In Commerce DateMonday, August 1, 2011

Trademark Owner History


Party NameBioved Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95131

Party NameBioved Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95131

Trademark Events


Event DateEvent Description
Wednesday, January 31, 2024NEW APPLICATION ENTERED
Saturday, June 1, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, June 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 26, 2024ASSIGNED TO EXAMINER
Wednesday, September 4, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 4, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 7, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, January 7, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, January 8, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 8, 2025TEAS PETITION TO REVIVE RECEIVED
Wednesday, January 8, 2025NOTICE OF REVIVAL - E-MAILED
Wednesday, January 8, 2025PETITION TO REVIVE-GRANTED
Wednesday, January 8, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 9, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, February 8, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025PUBLISHED FOR OPPOSITION